Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Weidinger

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2019
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermanyA Heratizadeh, E Haufe, D Stölzl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisA Wollenberg, C Flohr, D Simon, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
The British Journal of Dermatology|February 19, 2020
Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermanyS Abraham, E Haufe, I Harder, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2025
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforceA H Musters, L A A Gerbens, L van der Gang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologicsJ P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2026
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluationN G Koster, J M P A van den Reek, E M G J de Jong, et al.
The British Journal of Dermatology|July 21, 2016
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)J R Chalmers, E Simpson, C J Apfelbacher, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 14, 2019
Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermanyA Heratizadeh, E Haufe, D Stölzl, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisA Wollenberg, C Flohr, D Simon, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
The British Journal of Dermatology|February 19, 2020
Implementation of dupilumab in routine care of atopic eczema: results from the German national registry TREATgermanyS Abraham, E Haufe, I Harder, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 20, 2025
Baseline characteristics of atopic eczema patients enrolled in seven European registries united in the TREatment of ATopic eczema (TREAT) registry taskforceA H Musters, L A A Gerbens, L van der Gang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologicsJ P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 6, 2026
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluationN G Koster, J M P A van den Reek, E M G J de Jong, et al.
The British Journal of Dermatology|July 21, 2016
Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)J R Chalmers, E Simpson, C J Apfelbacher, et al.
Pageof 13